Penney Test (300887): Revenue performance is under pressure and waiting for demand to be released
Penney Test (300887) Company Dynamics Research: Performance is under pressure in the short term; waiting for an upward inflection point
Penney Test (300887): Short-term medical tests affect performance growth, waiting for net interest rate to be repaired
Dongwu Securities released a research report on April 26 stating that it gave the Penney Test (300887.SZ) an increase in holdings rating. The main reasons for the rating include: 1) Affected by the medical sector, the short-term pressure on the growth rat
Penney Test (300887) 2023 Report & 2024Q1 Quarterly Report Review: One-off impairment affects profit and expects profit recovery in 2024
Penney Test (300887): Impairment affects short-term performance and continues to build barriers to mergers and acquisitions
Penney Test (300887): 1Q24 performance under pressure, expectations for improved management to drive higher profit margins
Penney Test (300887): Performance continues to be under pressure, awaiting an upward inflection point in revenue
Penney test (300887): One-off impairment affects profits more, focus on improving slope in 2024
Penney Test (300887): The 23-year performance forecast falls short of expectations and is greatly affected by impairment losses
Pronie Test (300887): Traditional sectors are under pressure, mergers and acquisitions, and integration into the next city
Perney Test (300887): 2023Q3 performance under pressure due to demand and impairment
Penny Test (300887): Downstream projects delay Q3 performance under phased pressure
Penny Test (300887) 2023 Quarterly Report Review: Depreciation suppresses performance and production capacity continues to expand
Penny Test (300887): Decline in revenue and impairment drag down third-quarter results
Puni Test (300887) Company Review: Comprehensive Testing Leader Expands to Increase Biomedical Field
Beni Test (300887): The competitiveness of more than 50,000 new square meters of land has been further improved
Beni Test (300887): Non-nucleic acid business has grown significantly and new fields continue to gain strength
Profitability Test (300887): Rapid growth in core business and significant improvement in profitability
Profit Test (300887): Business Adjustment, Repair, and Optimize Margin Management to Improve Net Profit
No Data